Options Traders Make Big Bets As UnitedHealth Tops Q2 Expectations
Portfolio Pulse from Lisa Levin
UnitedHealth Group Incorporated (NYSE:UNH) reported Q2 FY23 sales of $92.9 billion, up almost 16% Y/Y, beating the consensus of $91 billion. Adjusted EPS of $6.14 increased 14% Y/Y, surpassing the consensus of $6.01. Options markets are implying a move of +/-3.5% by the end of Friday. UBS maintained UnitedHealth Group with a Neutral and lowered the price target from $550 to $510, while Wells Fargo maintained the stock with an Overweight and cut the price target from $616 to $561.

July 14, 2023 | 2:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UnitedHealth Group's Q2 results surpassed expectations, potentially leading to a positive short-term impact on its stock. However, lowered price targets by UBS and Wells Fargo may temper this impact.
UnitedHealth Group's better-than-expected Q2 results could lead to increased investor confidence and a short-term boost in its stock price. However, the lowered price targets by UBS and Wells Fargo suggest that these institutions see potential headwinds for the company, which could moderate the positive impact of the earnings beat.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100